Prospective Study
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. May 21, 2014; 20(19): 5889-5896
Published online May 21, 2014. doi: 10.3748/wjg.v20.i19.5889
Figure 1
Figure 1 HER2/neu overexpression in gastric carcinoma (HE, × 20). A: Photomicrograph showing well-differentiated non-mucinous colon adenocarcinoma; B: Photomicrograph showing expression of HER2/neu in well-differentiated non-mucinous colon adenocarcinoma; C: Photomicrograph showing the signet ring variant of stomach adenocarcinoma; D: Photomicrograph showing expression of HER2/neu in gastric carcinoma.
Figure 2
Figure 2 HER2/neu overexpression in colon adenocarcinoma (HE, × 20). A: Photomicrograph showing well-differentiated mucinous colon adenocarcinoma, B: Photomicrograph showing expression of HER2/neu in well-differentiated non-mucinous colon adenocarcinoma; C: Photomicrograph showing the signet ring variant of colon adenocarcinoma; D: Photomicrograph showing expression of HER2/neu in colonic carcinoma.